Md Ali Mujtaba
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 22
- Drug Solubulity and Delivery Systems 17
- Advancements in Transdermal Drug Delivery 11
- Pharmacology 10
- Berberine and alkaloids research 4
- Co-authors
- Kanchan Kohli (11 shared papers)Md Habban Akhter (6 shared papers)Saima Amin (3 shared papers)Mushir Ali (3 shared papers)Kriti Soni (3 shared papers)Javed Ahmad (2 shared papers)Md. Rizwanullah (2 shared papers)Javed Ali (4 shared papers)
- Journals
- International Journal of Biological Macromolecules (4 papers)Journal of Pharmaceutical Innovation (4 papers)RSC Advances (3 papers)Current Pharmaceutical Biotechnology (3 papers)Current Pharmaceutical Design (3 papers)
- Partner nations
- Saudi ArabiaIndiaEthiopia
In The Last Decade
Md Ali Mujtaba
64 papers receiving 921 citations
Peers
Comparison fields: 5 of 113
- Pharmaceutical Science 344
- Biomaterials 175
- Molecular Medicine 61
- Pharmacology 55
- Pharmacology 98
Countries citing papers authored by Md Ali Mujtaba
This map shows the geographic impact of Md Ali Mujtaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md Ali Mujtaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md Ali Mujtaba more than expected).
Fields of papers citing papers by Md Ali Mujtaba
This network shows the impact of papers produced by Md Ali Mujtaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md Ali Mujtaba. The network helps show where Md Ali Mujtaba may publish in the future.
Co-authors
The 25 scholars most cited alongside Md Ali Mujtaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 112 | |
| 2 | 2017 | 111 | |
| 3 | 2019 | 59 | |
| 4 | 2020 | 52 | |
| 5 | 2013 | 50 | |
| 6 | 2021 | 43 | |
| 7 | 2021 | 35 | |
| 8 | 2017 | 33 | |
| 9 | 2016 | 33 | |
| 10 | 2020 | 32 | |
| 11 | 2021 | 31 | |
| 12 | 2014 | 31 | |
| 13 | 2020 | 30 | |
| 14 | 2022 | 21 | |
| 15 | 2019 | 20 | |
| 16 | 2024 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2021 | 15 | |
| 19 | 2011 | 14 | |
| 20 | 2025 | 14 |
About Md Ali Mujtaba
Md Ali Mujtaba is a scholar working on Pharmaceutical Science, Pharmacology, Biomaterials, Analytical Chemistry and Pharmacology, having authored 72 papers that have together received 941 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (22 papers), Drug Solubulity and Delivery Systems (17 papers), Advancements in Transdermal Drug Delivery (11 papers), Nanoparticle-Based Drug Delivery (9 papers), Analytical Methods in Pharmaceuticals (7 papers), RNA Interference and Gene Delivery (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Berberine and alkaloids research (4 papers). The work is most often cited by research in Pharmaceutical Science (344 citations), Biomaterials (175 citations), Molecular Medicine (61 citations), Pharmacology (55 citations) and Pharmacology (98 citations). Md Ali Mujtaba has collaborated with scholars based in Saudi Arabia, India and Ethiopia. Frequent co-authors include Kanchan Kohli, Md Habban Akhter, Saima Amin, Mushir Ali, Kriti Soni, Javed Ahmad, Md. Rizwanullah, Javed Ali, Ameeduzzafar Zafar and Mohamed Jawed AHSAN. Their work appears in journals such as International Journal of Biological Macromolecules, Journal of Pharmaceutical Innovation, RSC Advances, Current Pharmaceutical Biotechnology and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.